Restart Life Sciences Corp.

NMLSFOTCHealthcare● Active

$0.04

+$0.00(+0.00%)

Market Cap$1279264

P/E Ratio—

52W High$0.12422

52W Low$0.0101

Avg Volume847

Open$0.12

Beta-0.81

Overview

Restart Life Sciences Corp. (NMLSF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

NMLSF · net income · updated Jun 15, 2026

Core profitability metrics

NMLSF · net income · margin · TTM · CAGR

Net income was −$1.4M for FY2025 (fiscal year ending 2025-12-31), down 718.7% year-over-year. Net profit margin was —. Based on available data, Restart Life Sciences Corp. has been profitable since at least 2024.

FY2025 Net Income−$1.4M▼ -718.7% YoY

Trailing 12M (TTM)−$898,770trailing 4 quarters sum

Net Profit Margin——

YoY Change-718.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · NMLSF net income history · NMLSF profit margin

Annual net income data

NMLSF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.4M▼ 718.7%—$0

FY2024★ First Profit$224,745▲ +118.4%—$0

FY2023Loss−$1.2M▲ +50.3%—$0

FY2022Loss−$2.5M▲ +8.1%—$0

FY2021Loss−$2.7M▲ +89.4%—$0

Net income vs peers (Healthcare)

NMLSF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Restart Life Sciences Corp.YOU

NMLSF

−$1.4M-718.7%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Restart Life Sciences Corp. (NMLSF) reported net income of −$1.4M for FY2025 (fiscal year ending 2025-12-31), down 718.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Restart Life Sciences Corp. has been profitable since at least 2024. Net income reached a peak of $224,745 in FY2024. Data available for 15 fiscal years.

Restart Life Sciences Corp.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Restart Life Sciences Corp. net worth" — the company's market capitalization is a separate figure from NMLSF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

NMLSF net income · 4 questions

Restart Life Sciences Corp. is not currently profitable on an annual basis. The company reported a net loss of $1.4M for FY2025.

is NMLSF profitabledoes NMLSF make a profitNMLSF profitabilityNMLSF profitable company

▸ Source: FMP /income-statement · GAAP · Restart Life Sciences Corp. · Restart Life Sciences Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026